Flamel Technologies SA (NASDAQ:FLML) was up 3.7% during mid-day trading on Thursday . The stock traded as high as $13.95 and last traded at $13.87, with a volume of 122,945 shares traded. The stock had previously closed at $13.37.

Several equities research analysts have issued reports on FLML shares. Leerink Swann reissued a “buy” rating and set a $16.00 target price on shares of Flamel Technologies SA in a research note on Tuesday, May 10th. Zacks Investment Research cut Flamel Technologies SA from a “hold” rating to a “sell” rating in a research note on Tuesday, May 10th. Two research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The company presently has an average rating of “Buy” and a consensus target price of $18.63.

The stock has a market capitalization of $572.01 million and a price-to-earnings ratio of 33.58. The company has a 50-day moving average of $13.15 and a 200-day moving average of $11.12.

Flamel Technologies SA (NASDAQ:FLML) last announced its quarterly earnings results on Monday, August 8th. The company reported ($0.02) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.06 by $0.08. The firm earned $38.90 million during the quarter, compared to analyst estimates of $32.80 million. Flamel Technologies SA’s quarterly revenue was down 20.0% on a year-over-year basis. During the same quarter last year, the business earned $0.34 earnings per share. Equities research analysts predict that Flamel Technologies SA will post ($1.11) EPS for the current year.

In related news, Director Craig R. Stapleton bought 20,000 shares of Flamel Technologies SA stock in a transaction that occurred on Friday, August 26th. The shares were purchased at an average price of $13.76 per share, with a total value of $275,200.00. Following the purchase, the director now owns 509,678 shares in the company, valued at $7,013,169.28. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Michael S. Anderson bought 5,000 shares of Flamel Technologies SA stock in a transaction that occurred on Monday, August 22nd. The stock was bought at an average cost of $14.30 per share, for a total transaction of $71,500.00. The disclosure for this purchase can be found here.

Flamel Technologies SA is a specialty pharmaceutical company. The Company is engaged in the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its polymer based technology. The Company has a balanced business model consisting of an Unapproved Marketed Drugs (UMDs) business with over two approved products in the United States, Bloxiverz (neostigmine methylsulfate injection) and Vazculep (phenylephrine hydrochloride injection) that are marketed; a branded pediatric business, and a branded business, focusing on the development of products utilizing Flamel’s drug delivery platforms.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.